Melatonin Level and Postoperative Analgesia Consumption in Bariatric Surgery Patients.

• Register: ClinicalTrials.gov
• Last refreshed on: 16 December 2017
• Main ID: NCT03107702
• Date of registration: 29/03/2017
• Prospective Registration: Yes
• Primary sponsor: Inonu University
• Public title: Melatonin Level and Postoperative Analgesia Consumption in Bariatric Surgery Patients.
• Scientific title: Relationship Between Melatonin Level and Postoperative Analgesia Consumption in Bariatric Surgery Patients.
• Date of first enrolment: March 29, 2017
• Target sample size: 35
• Recruitment status: Enrolling by invitation
• URL: https://clinicaltrials.gov/show/NCT03107702
• Study type: Observational
• Phase: N/A

Countries of recruitment

Turkey

Contacts

• Name: Türkan Togal, Prof.
• Affiliation: Inonu University Faculty of Medicine

Key inclusion & exclusion criteria

Inclusion Criteria:

- American Society of Anesthesiologists (ASA) 3-4 status, aged between 18-65 years who
are scheduled to undergo bariatric surgery.

Exclusion Criteria:

Patients with cardiovascular and pulmonary disease, those with ASA III-IV and propofol,
fentanyl, remifentanil and rocuronium allergy.



Age minimum: 18 Years
Age maximum: 65 Years
Gender: All

Health Condition(s) or Problem(s) studied

Melatonin

POSTOPERATIVE PAIN

Bariatric Surgery

Intervention(s)

Diagnostic Test: melatonin

Primary Outcome(s)

Melatonin Level [Time Frame: Change from Baseline melatonin at postoperative 24 hours]

Secondary Outcome(s)

Morphine consumption [Time Frame: change from postoperative up to 24 hours]

Secondary ID(s)

MAE5

Source(s) of Monetary Support

Please refer to primary and secondary sponsors